• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Intra-arterial chemotherapy in advanced ovarian cancer. 1. Study conditions and prognostic factors].

作者信息

Lotze W, Richter P, Sarembe B

出版信息

Zentralbl Gynakol. 1987;109(7):443-9.

PMID:3303753
Abstract

The significance of intra-arterial chemotherapy in connection with progressive ovarial carcinomas was investigated within a prospective-randomized study. The patients were selected according to strict precaution in consideration of the factors of prognosis. After operative staging 43 patients got an intra-arterial infusion of MTX and 5-FU, later systematically CMFV (therapy arm A). 42 women were only systematically treated with the CMFV combination (therapy arm B). The histological grading proved as most important feature for the judgement of the malignant power of the tumors. A reliable correlation was found between stage, typing and grading of the tumor which is significant for the individual planning of therapy. A significant improvement of the results of survival could be achieved by intra-arterial therapy in a comparable initial state in both particular groups. This comes close to DDP containing combined schedules. Thus second-line drugs were available during repeated tumor progredience.

摘要

相似文献

1
[Intra-arterial chemotherapy in advanced ovarian cancer. 1. Study conditions and prognostic factors].
Zentralbl Gynakol. 1987;109(7):443-9.
2
[Intra-arterial chemotherapy in advanced ovarian cancers. 2. Therapeutic results in relation to prognostic factors].[晚期卵巢癌的动脉内化疗。2. 与预后因素相关的治疗结果]
Zentralbl Gynakol. 1987;109(9):578-85.
3
[Intra-arterial chemotherapy in advanced ovarian cancer. 2. Technic, results, complications].[晚期卵巢癌的动脉内化疗。2. 技术、结果、并发症]
Zentralbl Gynakol. 1987;109(8):532-9.
4
[Intra-arterial chemotherapy with methotrexate and 5-fluorouracil in extensive locoregional recurrences of cervix cancer].
Zentralbl Gynakol. 1988;110(18):1138-44.
5
[Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients].[奥地利首个多中心卵巢癌研究结果:III期和IV期患者中序贯化疗(阿霉素/顺铂 - 长春新碱/环磷酰胺 - 甲氨蝶呤)与2种标准方案(阿霉素/环磷酰胺或阿霉素/顺铂)的前瞻性随机比较]
Geburtshilfe Frauenheilkd. 1985 Nov;45(11):761-8. doi: 10.1055/s-2008-1036132.
6
[Postoperative radio- and/or chemotherapy in ovarian stage III cancers. Results of a prospective randomized study].
Zentralbl Gynakol. 1985;107(4):237-44.
7
Medical therapy of advanced malignant epithelial tumours of the ovary.晚期卵巢恶性上皮性肿瘤的医学治疗
Forum (Genova). 2000 Oct-Dec;10(4):323-32.
8
[Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].晚期卵巢癌化疗的对照前瞻性研究——环磷酰胺单药化疗与阿霉素、环磷酰胺、5-氟尿嘧啶和甲氨蝶呤联合化疗的对比
Lijec Vjesn. 1987 Jun;109(6):230-4.
9
Clinical controlled trial in advanced breast cancer: CMFV (cyclophosphamide, methotrexate, fluorouracil, vincristine) verus CD (carminomycin, dibromodulcitol).
Neoplasma. 1982;29(6):741-7.
10
[Treatment of 63 advanced ovarian carcinomas].[63例晚期卵巢癌的治疗]
Zhonghua Zhong Liu Za Zhi. 1987 Sep;9(5):375-8.